ACE2 and dementia: Articles published in 2020 were structured around the themes of “Alzheimer's disease,” “ACE-2(angiotensin-converting enzyme-2),” “caregiver,” and “dementia.” Namely “neurodegeneration,” which was the primary concern in 2021.